BCTX
Price
$7.87
Change
+$0.15 (+1.94%)
Updated
Sep 5 closing price
Capitalization
13.68M
KROS
Price
$15.59
Change
+$0.04 (+0.26%)
Updated
Sep 5 closing price
Capitalization
633.19M
54 days until earnings call
Interact to see
Advertisement

BCTX vs KROS

Header iconBCTX vs KROS Comparison
Open Charts BCTX vs KROSBanner chart's image
Briacell Therapeutics Corp NEW
Price$7.87
Change+$0.15 (+1.94%)
Volume$16.19K
Capitalization13.68M
Keros Therapeutics
Price$15.59
Change+$0.04 (+0.26%)
Volume$537.58K
Capitalization633.19M
BCTX vs KROS Comparison Chart in %
Loading...
BCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCTX vs. KROS commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCTX is a Hold and KROS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (BCTX: $7.87 vs. KROS: $15.59)
Brand notoriety: BCTX and KROS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCTX: 10% vs. KROS: 119%
Market capitalization -- BCTX: $13.68M vs. KROS: $633.19M
BCTX [@Biotechnology] is valued at $13.68M. KROS’s [@Biotechnology] market capitalization is $633.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCTX’s FA Score shows that 1 FA rating(s) are green whileKROS’s FA Score has 1 green FA rating(s).

  • BCTX’s FA Score: 1 green, 4 red.
  • KROS’s FA Score: 1 green, 4 red.
According to our system of comparison, KROS is a better buy in the long-term than BCTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCTX’s TA Score shows that 3 TA indicator(s) are bullish while KROS’s TA Score has 6 bullish TA indicator(s).

  • BCTX’s TA Score: 3 bullish, 4 bearish.
  • KROS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, KROS is a better buy in the short-term than BCTX.

Price Growth

BCTX (@Biotechnology) experienced а +1.29% price change this week, while KROS (@Biotechnology) price change was +2.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

KROS is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KROS($633M) has a higher market cap than BCTX($13.7M). KROS YTD gains are higher at: -1.516 vs. BCTX (-90.714). KROS has more cash in the bank: 690M vs. BCTX (44.5M). BCTX has less debt than KROS: BCTX (27K) vs KROS (18M).
BCTXKROSBCTX / KROS
Capitalization13.7M633M2%
EBITDAN/A25.5M-
Gain YTD-90.714-1.5165,983%
P/E RatioN/A48.72-
RevenueN/A233M-
Total Cash44.5M690M6%
Total Debt27K18M0%
FUNDAMENTALS RATINGS
BCTX: Fundamental Ratings
BCTX
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCTXKROS
RSI
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
75%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 9 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
BCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AVTX11.601.44
+14.17%
Avalo Therapeutics
ZLAB30.760.76
+2.53%
Zai Lab Limited
MLEC1.180.01
+0.43%
Moolec Science SA
VLTO105.71-0.89
-0.83%
Veralto Corp
NGL5.75-0.05
-0.86%
NGL Energy Partners LP

BCTX and

Correlation & Price change

A.I.dvisor tells us that BCTX and PDSB have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BCTX and PDSB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCTX
1D Price
Change %
BCTX100%
+2.01%
PDSB - BCTX
28%
Poorly correlated
-1.64%
KROS - BCTX
28%
Poorly correlated
+0.26%
LGVN - BCTX
26%
Poorly correlated
+5.84%
GNPX - BCTX
25%
Poorly correlated
+47.40%
PLRX - BCTX
24%
Poorly correlated
+14.11%
More

KROS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KROS has been loosely correlated with INO. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if KROS jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KROS
1D Price
Change %
KROS100%
+0.26%
INO - KROS
52%
Loosely correlated
+1.45%
ANAB - KROS
41%
Loosely correlated
+3.84%
DNLI - KROS
39%
Loosely correlated
+4.33%
XNCR - KROS
38%
Loosely correlated
+2.15%
ALT - KROS
38%
Loosely correlated
+6.18%
More